VERAXA Biotech Designates Raju Willener as CFO
By Karen Roman
Veraxa Biotech AG (Nasdaq: VRXA) said it appointed Raju Willener as Chief Financial Officer, having previously served as Director of Corporate Development at Exentis Group AG, before becoming its CFO in 2025.
Mr. Willener has more than three decades of international financial leadership experience in global capital markets and all aspects of the biopharmaceutical development process, the company stated.
READ MORE
Chris Benecchi Named Inventiva’s New Chief Operating Officer
“As we advance our proprietary BiTAC technology platform and growing oncology pipeline, Raju’s expertise will be highly valuable in optimizing our capital strategy, evaluating strategic opportunities and supporting disciplined execution and long-term shareholder value creation,” said Christoph Antz, Ph.D., VERAXA’s CEO and co-founder.
Never Miss our Weekly Highlights HERE
Contact:
Exec Edge
Editor@executives-edge.com
Click HERE to follow us on LinkedIn
The post VERAXA Biotech Designates Raju Willener as CFO appeared first on ExecEdge .